Stockreport

ImmunityBio Bladder Cancer Milestone Raises Questions On Global ANKTIVA Rollout [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. ImmunityBio (NasdaqGS:IB [Read more]